[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 134,427,824
  • Shares Outstanding, K 253,805
  • Annual Sales, $ 12,001 M
  • Annual Income, $ 3,953 M
  • EBIT $ 4,777 M
  • EBITDA $ 4,987 M
  • 60-Month Beta 0.30
  • Price/Sales 11.08
  • Price/Cash Flow 29.81
  • Price/Book 6.57

Options Overview Details

View History
  • Implied Volatility 25.20% (+0.67%)
  • Historical Volatility 32.53%
  • IV Percentile 14%
  • IV Rank 12.94%
  • IV High 46.24% on 02/12/26
  • IV Low 22.08% on 08/27/25
  • Expected Move (DTE 2) 6.89 (1.31%)
  • Put/Call Vol Ratio 0.38
  • Today's Volume 979
  • Volume Avg (30-Day) 3,244
  • Put/Call OI Ratio 1.14
  • Today's Open Interest 51,110
  • Open Int (30-Day) 50,224
  • Expected Range 518.69 to 532.46

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 30 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $4.37
  • Number of Estimates 6
  • High Estimate $4.46
  • Low Estimate $4.23
  • Prior Year $4.22
  • Growth Rate Est. (year over year) +3.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
465.00 +13.23%
on 07/23/26
546.17 -3.60%
on 08/10/26
+41.13 (+8.47%)
since 07/10/26
3-Month
420.01 +25.36%
on 06/03/26
546.17 -3.60%
on 08/10/26
+78.23 (+17.45%)
since 05/12/26
52-Week
374.17 +40.72%
on 09/24/25
546.17 -3.60%
on 08/10/26
+138.75 (+35.78%)
since 08/12/25

Most Recent Stories

More News
5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call

5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call

VRTX : 525.83 (-0.72%)
Vertex Pharmaceuticals (NASDAQ:VRTX) Beats Q2 CY2026 Sales Expectations, Full-Year Outlook Slightly Exceeds Expectations

Vertex Pharmaceuticals (NASDAQ:VRTX) Beats Q2 CY2026 Sales Expectations, Full-Year Outlook Slightly Exceeds Expectations

VRTX : 525.83 (-0.72%)
Vertex: Q2 Earnings Snapshot

Vertex: Q2 Earnings Snapshot

VRTX : 525.83 (-0.72%)
Vertex Reports Second Quarter 2026 Financial Results

— Total revenue of $3.33 billion, a 12% increase compared to second quarter 2025 — — Raising full-year revenue guidance to $13.1 billion to $13.2 billion — ...

VRTX : 525.83 (-0.72%)
Jobs Numbers Set for Release Next Week

Monday U.S. Economic Lookahead S&P final U.S. manufacturing PMI (July) ISM manufacturing ...

SONY : 23.53 (-0.34%)
SNDK : 1,340.69 (+5.48%)
COP : 127.23 (+1.04%)
NVO : 46.20 (-2.06%)
CAT : 858.44 (+1.79%)
MRK : 133.75 (+2.55%)
VRTX : 525.83 (-0.72%)
AMD : 483.44 (+1.92%)
LLY : 1,219.96 (+0.41%)
PH : 1,070.05 (+0.82%)
PLTR : 171.31 (-2.07%)
MAR : 354.87 (+1.54%)
Vertex Pharmaceuticals (VRTX) Q2 Earnings Report Preview: What To Look For

Vertex Pharmaceuticals (VRTX) Q2 Earnings Report Preview: What To Look For

VRTX : 525.83 (-0.72%)
Vertex: The Cystic Fibrosis Franchise Meets Its First Real Comps Test

Barchart Research What to Expect from VRTX Earnings VRTX Generated July 31, 2026 Current Price $477.10 EPS Estimate $$4.30 Consensus Rating Moderate Buy Average Move 6.21% Vertex: The Cystic Fibrosis Franchise...

VRTX : 525.83 (-0.72%)
AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions

AbCellera (Nasdaq: ABCL) today announced a collaboration with Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) to research, develop, manufacture, and commercialize multispecific T-cell engagers...

ABCL : 10.24 (+4.92%)
VRTX : 525.83 (-0.72%)
3 Healthcare Stocks with Competitive Advantages

3 Healthcare Stocks with Competitive Advantages

VRTX : 525.83 (-0.72%)
ZTS : 73.50 (-2.46%)
ALHC : 13.44 (+1.82%)
1 Nasdaq 100 Stock to Keep an Eye On and 2 We Question

1 Nasdaq 100 Stock to Keep an Eye On and 2 We Question

MDLZ : 61.97 (+0.31%)
VRTX : 525.83 (-0.72%)
WDAY : 174.54 (-3.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 70%. The market has dropped from overbought territory. Beware of a potential mean reversion.

See More Share

Business Summary

Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which...

See More

Key Turning Points

3rd Resistance Point 544.14
2nd Resistance Point 538.18
1st Resistance Point 533.92
Last Price 525.83
1st Support Level 523.70
2nd Support Level 517.74
3rd Support Level 513.48

See More

52-Week High 546.17
Last Price 525.83
Fibonacci 61.8% 480.47
Fibonacci 50% 460.17
Fibonacci 38.2% 439.87
52-Week Low 374.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.